全球胆结石溶解剂市场 – 行业趋势和 2029 年预测

 市场分析和规模  

胆结石是胆囊中凝固的消化液沉积物。它们可以由胆固醇、盐或胆红素组成，大小各异。它们的大小从一粒沙子到一颗杏子不等。根据美国胃肠病学协会 2017 年的一份报告，胆结石每年困扰着 10-15% 的美国人口，即大约 2500 万人。随着人们在饮食中摄入更多的脂肪和胆固醇，胆结石变得越来越普遍。所有这些因素导致市场上出现了胆结石溶解剂。

Data Bridge Market Research 分析称，胆结石溶解剂市场在 2021 年的价值为 5.3498 亿美元，预计到 2029 年将达到 7.2319 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 4%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

市场定义

胆结石溶解剂可溶解小的非钙化胆结石。它们可减少肝脏产生的胆固醇量或阻止胆固醇被肠道吸收。它们可用于溶解不需要手术的胆结石患者。

报告范围和市场细分

Gallstone Solubilizing Agents? Market Dynamics

Drivers

• Rise in the prevalence of gallbladder disease

The rising prevalence of gallbladder disease is anticipated to enhance the antifungal drugs market's growth rate. Along with this, the growing incidences of primary biliary cholangitis will propel the demand for gallstone solubilizing agents? in the market during the forecast period.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of gallstone solubilizing agents? market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the gallstone solubilizing agents? market. Additionally, high disposable income and changing lifestyle of people will result in the expansion of gallstone solubilizing agents? market. Along with this, rising geriatric population and favourable reimbursement scenario will enhance the market's growth rate.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the gallstone solubilizing agents? market growth. The surge in drug approvals and new product launches will further propel the market's growth rate.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the gallstone solubilizing agents? market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the drug development and distribution? will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and low awareness among people will challenge the gallstone solubilizing agents? market. Additionally, side effects of gallstone solubilizing agents? including nausea, vomiting, dizziness, hair loss, back pain, cough, and others will act as market restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This gallstone solubilizing agents? market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gallstone solubilizing agents? market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Gallstone solubilizing agents? market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Gallstone Solubilizing Agents ? Market

Over the projected period, the gallstone solubilizing agents market is expected to be constrained by the COVID-19 outbreak. Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations have imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world are having difficulty continuing their supply chain activities. The supply chain slowness has also hampered the gallstone solubilizing agents? market.

全球胆结石溶解剂？市场范围

胆结石溶解剂市场根据药物类型、应用、剂型、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

药物类型

• 熊去氧胆酸
• 鹅去氧胆酸

应用

• 胆囊疾病
• 原发性胆汁性胆管炎
• 其他的

剂型

• 胶囊
• 药片
• 其他的

给药途径

• 口服
• 其他的

最终用户

• 医院
• 专科诊所
• 家庭护理
• 其他的

分销渠道

• 医院药房
• 零售药店
• 网上药店
• 其他的

胆结石溶解剂市场区域分析/见解

对胆结石增溶剂市场进行了分析，并按国家、药物类型、应用、剂型、给药途径、最终用户和分销渠道提供了市场规模见解和趋势，如上所述。

胆结石增溶剂市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区

北美在胆结石溶解剂市场占据主导地位，因为该地区的研发活动数量不断增加。此外，主要关键参与者的不断增加和完善的医疗保健基础设施将进一步推动该地区市场的增长率。

由于医疗支出不断增加以及政府为改善该地区医疗基础设施而采取的举措不断增加，预计亚太地区将在 2022 年至 2029 年的预测期内实现增长。此外，老年人口的增加和可支配收入水平的提高将进一步推动该地区市场的增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和胆结石溶解剂市场份额分析

胆结石增溶剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对胆结石增溶剂市场的关注有关。

胆结石溶解剂市场的一些主要参与者是：

• Dipharma Francis Srl（意大利）
• ERREGIERRE SpA（意大利）
• Grindeks（拉脱维亚）
• ICE SpA（意大利）
• 中山贝岭生物科技有限公司（中国）
• Abil Chempharma Private Limited（印度）
• Biotavia（印度）
• DAEWOONG BIO（韩国）
• PharmaZell GmbH（德国）
• 苏州天璐生物制药有限公司 (中国)
• Glenmark 制药有限公司（印度）
• 田边三菱制药株式会社（日本） 

SKU-68130